Important Safety Information: CERDELGA can affect how other medicines work and other medicines can affect how CERDELGA works. Especially tell your doctor if you take medicines for fungal infections, tuberculosis, seizures, heart rhythm and rate problems, high blood pressure, or depression. Tell your doctor about all of your medical conditions, including history of heart attacks or heart rhythm problems.View more

FDA Approved: Cerdelga® (eliglustat) Capsules


Call a Genzyme Case Manager to Learn More

Call a Genzyme Case Manager to Learn More

1-800-745-4447 (opt#3)

Download Prescribing Information

Click here to download PDF

Prescribing Information

Cerdelga: A First-Line Oral Treatment

CERDELGA is a glucosylceramide synthase inhibitor indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test.

CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA to achieve a therapeutic effect. A specific dose cannot be recommended for CYP2D6 indeterminate metabolizers.


Talk to your doctor to find out if Cerdelga is right for you

Whether you are newly diagnosed or have been living with Gaucher disease for many years, Cerdelga may be a treatment option for you.

Because of the way it works, Cerdelga may not be right for everyone. Before being prescribed Cerdelga, your doctor will need to perform a blood test to help determine if Cerdelga is right for you.


Contact Genzyme at 1-800-745-4447 (option #3) to learn more.


Indication & Usage

CERDELGA (eliglustat) capsules is a glucosylceramide synthase inhibitor indicated for the long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test. CYP2D6 ultra-rapid metabolizers may not achieve adequate concentrations of CERDELGA to achieve a therapeutic effect. A specific dose cannot be recommended for CYP2D6 indeterminate metabolizers.

Important Safety Information

CERDELGA (eliglustat) capsules are a prescription medicine used for the long-term treatment of Gaucher disease type 1 (GD1) in certain adults. Your doctor will perform a test to help determine if CERDELGA is right for you. It is not known if CERDELGA is safe and effective in children.

Before taking CERDELGA, tell your doctor about all of your medical conditions, including kidney or liver problems, history of heart attacks, or heart rhythm problems (including long QT syndrome). If you are pregnant or plan to become pregnant or breastfeed, talk to your physician. It is not known if CERDELGA will harm your unborn baby.

CERDELGA can affect the way other medicines work and other medicines can affect how CERDELGA works. Using CERDELGA with other medicines or herbal supplements (including St. John’s Wort) may cause an increased risk of side effects, including ECG changes and irregular heart beat. Especially tell your doctor if you take medicines for fungal infections, tuberculosis, seizures, heart rhythm and rate problems, high blood pressure, or depression or other mental health problems. Your doctor may need to prescribe a different medicine, change your dose of other medicines, or change your dose of CERDELGA. Tell your doctor about any new medicines before you start taking them.

Swallow the capsule whole. If you miss a dose of CERDELGA, take the next dose at the usual time. Do not take two doses of CERDELGA at the same time. Avoid eating or drinking grapefruit products while taking CERDELGA. Grapefruit products can increase the amount of CERDELGA in your body.

The most common adverse reactions (≥10%) for CERDELGA are: fatigue, headache, nausea, diarrhea, back pain, pain in extremities, and upper abdominal pain. Call your doctor for medical advice about adverse effects.

You may report adverse effects to FDA at 1-800-FDA-1088. If you would like more information, talk with your doctor. You may also go to www.cerdelga.com for the Full Prescribing Information, including the Patient Medication Guide, or call Genzyme Corporation at 1-800-745-4447.